19F NMR in the measurement of binding affinities of chloroeremomycin to model bacterial cell-wall surfaces that mimic VanA and VanB resistance

Chemistry and Biology

Volumn 5, Issue 6, 1998, Pages 329-337

  Entress, Richard M H ^a   Dancer, Robert J ^a   O'Brien, Dominic P ^a   Try, Andrew C ^a   Cooper, Matthew A ^a   Williams, Dudley H ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Glycopeptides; Model bacterial cell wall surfaces; VanA and VanB resistance

Indexed keywords

STAPHYLOCOCCUS AUREUS;

ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; CHLOROEREMOMYCIN; DRUG DERIVATIVE; FLUORINE; LIGASE; VANA LIGASE, BACTERIA; VANB PROTEIN, ENTEROCOCCUS; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BIOLOGICAL MODEL; CELL WALL; CHEMISTRY; DRUG EFFECT; ENTEROCOCCUS; METABOLISM; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN BINDING; SURFACE PROPERTY;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CARBON-OXYGEN LIGASES; CELL WALL; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS; FLUORINE; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, BIOLOGICAL; PROTEIN BINDING; SURFACE PROPERTIES; VANCOMYCIN;

EID: 0031595843     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(98)90171-5     Document Type: Article

References (29)

1. Perkins, H.R. (1969). Specificity of combination between mucopeptide precursors and vancomycin or ristocetin. Biochem. J. 111, 195-205.
2. Nieto, M. & Perkins, H.R. (1971). Modifications of the acyl-D-alanyl-D-alanine terminus affecting complex-formation with vancomycin. Biochem. J. 123, 780-803.
3. Foldes, M., Munro, R., Sorrell, T.C., Shankar, S. & Toohey, M. (1983). In vitro effects of vancomycin, rifampicin, fusidic acid, alone and in combination, against methicillin resistant Staphylococcus aureus. J. Antimicrob. Chemother. 11, 21-26.
4. Neu, H.C. (1992). The crisis in antibiotic resistance. Science 257, 1064-1073.
5. Mackay, J.P., Gerhard, U., Beauregard, D.A., Westwell, M.S., Searle, M.S. & Williams, D.H. (1994). Glycopeptide antibiotic acitivity and the possible role of dimerization: A model for biological signaling. J. Am. Chem. Soc. 116, 4581-4590.
6. Waltho, J.P. & Williams, D.H. (1989). Aspects of molecular recognition: solvent exclusion and dimerization of the antibiotic ristocetin when bound to a model bacterial cell wall precursor. J. Am. Chem. Soc. 111, 2475-2480.
7. Gerhard, U., Mackay, J.P., Maplestone, R.A. & Williams, D.H. (1993). The role of the sugar and chlorine substituents in the dimerization of vancomycin antibiotics. J. Am. Chem. Soc. 115, 232-237.
8. Sharman, G.J., et al., & Williams, D.H. (1997). The roles of dimerization and membrane anchoring in activity of glycopeptide antibiotics against vancomycin-resistant bacteria. J. Am. Chem. Soc. 119, 12041-12047.
9. Try, A.C., Sharman, G.J., Dancer, R.J., Bardsley, B., Entress, R.M.H. & Williams, D.H. (1997). Use of model cell membranes to demonstrate templated binding of vancomycin group antibiotics. J. Chem. Soc., Perkin Trans. 1, 2911-2917.
10. Mackay, J.P., Gerhard, U., Beauregard, D.A., Maplestone, R.A. & Williams, D.H. (1994). Dissection of the contributions toward dimerisation of glycopeptide antibiotics. J. Am. Chem. Soc. 116, 4573-4580.
11. Beauregard, D.A., Maguire, A.J., Williams, D.H. & Reynolds, P.E. (1997). Semiquantitation of cooperativity in binding of vancomycin-group antibiotics to vancomycin-susceptible and resistant organisms. Antimicrob. Agents Chemother. 41, 2418-2423.
12. Wright, G.D. & Walsh, C.T. (1992). D-Alanyl-D-alanine ligases and the molecular mechanism of vancomycin resistance. Accounts Chem. Res. 25, 468-473.
13. Walsh, C.T., Fisher, S.L., Park, I.-S., Prahalad, M. & Wu, Z. (1996). Bacterial resistance to vancomycin: five genes and one missing hydrogen bond tell the story. Chem. Biol. 3, 21-28.
14. Courvalin, P. (1990). Resistance of enterococci to glycopeptides. Antimicrob. Agents Chemother. 34, 2291-2296.
15. Hospital Infection Control Practices Advisory Committee (1995). Recommendations for preventing the spread of vancomycin resistance. Infect. Control Hosp. Epidemiol. 16, 105-113.
16. Johnson, A.P., Uttley, A.H.C., Woodford, N. & George, R.C. (1990). Resistance to vancomycin and teicoplanin: an emerging clinical problem. Clin. Microbiol. Rev. 3, 280-291.
17. Westwell, M.S., Bardsley, B., Dancer, R.J., Try, A.C. & Williams, D.H. (1996). Cooperativity in ligand binding expressed at a model cell membrane by the vancomycin group antibiotics. Chem. Commun., 589-590.
18. Cho, Y.R., Entress, R.M.H. & Williams, D.H. (1997). Synthesis of cell-wall analogues of vancomycin-resistant enterococci using solid phase peptide synthesis. Tetrahedron Lett. 38, 5229-5232.
19. 19F NMR. Chem. Eur. J. 4, 740-744.
20. Searle, M.S., Williams, D.H. & Gerhard, U. (1992). Partitioning of free energy contributions in the estimation of binding constants: residual motions and consequences for amide-amide hydrogen bond strengths. J. Am. Chem. Soc. 114, 10697-10704.
21. Bardsley, B. & Williams, D.H. (1997). Measurement of the different affinities of the two halves of glycopeptide dimers for acetate. Chem. Commun. 1049-1050.
22. Searle, M.S., et al., & Williams, D.H. (1996). Enthalpic (electrostatic) contribution to the chelate effect: a correlation between ligand binding constant and a specific hydrogen bond strength in complexes of glycopeptide antibiotics with cell wall analogues. J. Chem. Soc., Perkin Trans. 1 2781-2786.
23. Prowse, W.G., Kline, A.D., Skelton, M.A. & Loncharich, R.J. (1995). Conformation of A82846B, a glycopeptide antibiotic, cornplexed with its cell wall fragment: an asymmetric homodimer determined using NMR spectroscopy. Biochemistry 34, 9632-9644.
24. Cooper, M.A., Williams, D.H. & Cho, Y.R. (1997). Surface plasmon resonance analysis of glycopeptide antibiotic activity at a model membrane surface. Chem. Commun. 1625-1626.
25. Cooper, R.D.G., et al., & Thompson, R.C. (1996). Reductive alkylation of glycopeptide antibiotics: synthesis and antibacterial activity. J. Antibiot. 49, 575-581.
26. Allen, N.E., LeTourneau, D.L. & Hobbs Jr, J.N. (1997). The role of hydrophobic sidechains as determinants of antibacterial activity of semisynthetic glycopeptide antibiotics. J. Antibiot. 50, 677-684.
27. Nicas, T.I., et al., & Cooper, R.D.G. (1996). Semisynthetic glycopeptide antibiotics derived from LY264826 active against vancomycin-resistant enterococci. Antimicrob. Agents Chemother. 40, 2194-2199.
28. Perrin, D.D., Armarego, W.L.F. & Perrin, D.R. (1980). Purification of Laboratory Chemicals. (2nd), Pergamon Press, Oxford.
29. Macdonald, R.C., Macdonald, R.I., Menco, B.P., Takeshita, K., Subbarao, N.K. & Hu, L. (1991). Small-volume extrusion apparatus for preparation of large, unilamellar vesicles. Biochim. Biophys. Acta 1061, 297-303.